FUNDAMENTALS OF MS CARE – PART 3: CURRENT AND EMERGING THERAPIES AND SYMPTOM MANAGEMENT
Session 3 of Fundamentals offers an insight into multidisciplinary considerations to include DMTs, practical nursing approaches to...
CHOICES & CONTROVERSIES IN MS MANAGEMENT: A PRO/CON CASE-BASED DISCUSSION
This interactive case-based symposium will highlight contemporary controversies in MS disease management. Three debates will be moderated...
Assessing Patient-Reported Outcomes and Pharmacist Interventions in Multiple Sclerosis within an Integrated Care Center
Background: Patient-reported outcomes (PROs) responses can be used to measure patients health status, functioning, quality of life, and...
Continued Expansion of a Multiple Sclerosis Pharmacy Program
Background: Kaiser Permanente Washington (KPWA) launched a Multiple Sclerosis (MS) Pharmacy Program in June 2014 to support patients on...
Integrated Clinic-Based Pharmacist Impact on Time to Fingolimod Treatment Initiation
Background: Multiple Sclerosis (MS) has no cure and causes irreversible damage to the brain and spinal cord leading to physical and...
Treatment Resistant Tinea Corporis in Multiple Sclerosis Patients Treated with Ocrelizumab
Background: Tinea corporis is a fungal infection of the skin excluding the face, hands, feet, scalp, nail, or groin. It mostly affects the...